Gilde Healthcare Partners et al. back Definiens

Other investors included existing backers TVM Capital, Cipio and management. Definiens will use the funding for commercial expansion and to commercialise new products.

The company received €3m of early-stage funding from TVM in 2000 followed by a €6m expansion round from TVM, DaimlerChrysler Venture and Süd Venture Capital in 2001.

Company
Definiens provides image analysis solutions for digital pathology. Its products are predominantly used for research and development by pharmaceutical companies but they find increasing use in tissue-based diagnostic biomarker development. The company's proprietary product is Cognition Network Technology®.

Definiens is headquartered in Munich with offices throughout the United States. The company was founded as Delphi2 Creative Technologies in 1994 by Nobel laureate Professor Gerd Binnig and Dieter Herold and was initially financed by the Federal Environmental Foundation.

People
Janke Dittmer, partner at Gilde Healthcare Partners, led the deal and joined the company's supervisory board.

 

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Technology
• DACH
• Germany